DZ Bank
INDV icon

DZ Bank’s Indivior Pharmaceuticals INDV Stock Holding History

DZ Bank’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-42,826
Closed -$1.03M – 1010
2025
Q3 		$1.03M Buy
+42,826
New +$896K ﹤0.01% 696
2024
Q3 		– Sell
-126,542
Closed -$1.98M – 1020
2024
Q2 		$1.98M Buy
126,542
+597
+0.5% +$10.8K ﹤0.01% 581
2024
Q1 		$2.7M Sell
125,945
-51,031
-29% -$959K ﹤0.01% 552
2023
Q4 		$2.67M Buy
176,976
+61,772
+54% +$1.1M ﹤0.01% 535
2023
Q3 		$2.5M Buy
115,204
+99,714
+644% +$2.27M ﹤0.01% 535
2023
Q2 		$359K Buy
+15,490
New +$355K ﹤0.01% 789

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
MAP
Madison Avenue Partners New York $2.32B AUM 132.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

DZ Bank's INDV Position: Q4 2025 in Review

DZ Bank sold out of Indivior Pharmaceuticals (INDV) in Q4 2025, closing a stake of 42,826 shares — an estimated $1.03M sold.

DZ Bank first reported a position in INDV in Q2 2023 and held it in 6 quarters. The position peaked at $2.7M in Q1 2024. 259 funds tracked by Wall St. Rank hold INDV as of Q4 2025.

  • DZ Bank reported no remaining Indivior Pharmaceuticals position as of Q4 2025 after selling out during the quarter.
  • DZ Bank sold 42,826 Indivior Pharmaceuticals shares in Q4 2025, an estimated $1.03M.
  • DZ Bank first reported a position in Indivior Pharmaceuticals in Q2 2023 and held it in 6 quarters.
  • DZ Bank's Indivior Pharmaceuticals position peaked at $2.7M in Q1 2024.
  • 259 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q4 2025.

Based on DZ Bank's 13F filing for Q4 2025, filed 17 Feb 2026.